» Articles » PMID: 15769439

Idiopathic Dyspepsia

Overview
Specialty Gastroenterology
Date 2005 Mar 17
PMID 15769439
Authors
Affiliations
Soon will be listed here.
Abstract

Idiopathic dyspepsia refers to pain and/or discomfort perceived in the epigastrium that is not secondary to organic, systemic, or metabolic diseases. Symptoms may overlap with those of gastroesophageal reflux disease and irritable bowel syndrome. Gastrointestinal motor disorders, hypersensitivity to mechanical or chemical stimuli, and psychosocial factors can act individually or in concert to induce the symptoms of dyspepsia. Accordingly, there is no single therapy, and treatment must be individualized. Eradication of Helicobacter pylori infection rarely achieves symptom improvement. Treatment of idiopathic dyspepsia should begin by reassuring the patient about the benign nature of the syndrome and educating them on the knowledge that has been achieved in recent years regarding potential causes of the syndrome. Both prokinetic and antisecretory drugs have been reported to improve dyspeptic symptoms, but results are not completely convincing. Although well-designed studies demonstrate superiority of proton pump inhibitors over placebo, it should be noted that patients with nonerosive gastroesophageal reflux disease were invariably included; when these patients are excluded, the benefit of antisecretory medications is questionable. We suggest that patients with idiopathic dyspepsia be initially treated according to the predominant symptom. Those with epigastric pain/burning should receive a trial with standard doses of proton pump inhibitors for 4 to 8 weeks, whereas prokinetic patients should be prescribed at recommended doses for similar periods of time to patients with nonpainful dyspeptic symptoms such as posprandial fullness, early satiety, nausea, or vomiting. Nonresponders may benefit from combination therapies or short trials with higher doses of drugs. Visceral analgesics and antidepressants can also be prescribed alone or in combinations with other therapeutic strategies. Recent studies demonstrate utility for psychologic therapy and hypnotherapy, although truly controlled studies are difficult in this area. Herbal medicines deserve further evaluation.

References
1.
Delaney B, Moayyedi P, Deeks J, Innes M, Soo S, Barton P . The management of dyspepsia: a systematic review. Health Technol Assess. 2001; 4(39):iii-v, 1-189. DOI: 10.3310/hta4390. View

2.
El-Omar E, Penman I, Ardill J, McColl K . A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut. 1995; 36(4):534-8. PMC: 1382492. DOI: 10.1136/gut.36.4.534. View

3.
DiBaise J, Quigley E . Efficacy of prolonged administration of intravenous erythromycin in an ambulatory setting as treatment of severe gastroparesis: one center's experience. J Clin Gastroenterol. 1999; 28(2):131-4. DOI: 10.1097/00004836-199903000-00009. View

4.
Stanghellini V, Malagelada J, Zinsmeister A, Go V, Kao P . Stress-induced gastroduodenal motor disturbances in humans: possible humoral mechanisms. Gastroenterology. 1983; 85(1):83-91. View

5.
Holtmann G, Adam B, Haag S, Collet W, Grunewald E, Windeck T . Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther. 2003; 18(11-12):1099-105. DOI: 10.1046/j.1365-2036.2003.01767.x. View